Researchers found that the stage 1 benchmark that providers use CPOE for at least 30 percent of eligible patients is unlikely to influence rates of death from heart failure and heart attack among hospitalized Medicare patients.
Click here to read the full story in Becker’s Hospital Review on meaningful use.
